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ABSTRACT 
Consanguineous unions have been associated with an increased susceptibility to various forms of 
inherited disease. Although consanguinity is known to contribute to recessive diseases, the 
potential role of consanguinity in certain common birth defects is less clear, particularly since the 
disease pathophysiology may involve genetic and environmental/epigenetic factors. In this study 
we ask whether consanguinity affects one of the most common birth defects, congenital heart 
disease, and identify areas for further research into these birth defects, since consanguinity may 
now impact health on a near-global basis. A systematic review of consanguinity in congenital 
heart disease was performed, focusing on non-syndromic disease, with the methodologies and 
results from studies of different ethnic populations compared. The risks for congenital heart 
disease have been assessed and summarized collectively and by individual lesion. The majority 
of studies support the view that consanguinity increases the prevalence of congenital heart 
disease, however the study designs differed dramatically. Only a few (n = 3) population-based 
studies that controlled for potential sociodemographic confounding were identified, and data on 
individual cardiac lesions were limited by case numbers. Overall the results suggest that the risk 
for congenital heart disease is increased in consanguineous unions in the studied populations, 
principally at first cousin level and closer, a factor that should be considered in empiric risk 
estimates in genetic counseling.  However, for more precise risk estimates a better understanding 
of the underlying disease factors is needed. 
 
Key words: Consanguinity, congenital heart defects, risk factors, genetics, environment, genetic 
counseling 
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INTRODUCTION 
  Consanguineous unions afford the possibility that susceptibility genes identical by 
descent may be inherited through the relatedness of child-bearing couples, potentially leading to 
disease depending on the prevalence of consanguineous unions and the genetic contribution to 
disease. For common birth defects such as congenital heart disease (CHD), which are thought to 
have a genetic component, consanguinity may contribute to the risk of disease, particularly since 
the prevalence of consanguinity reaches over 50% in some areas of the world and in certain 
populations [Bittles 2008; Modell and Darr 2002]. The purpose of this article is to determine the 
potential role of consanguinity as a risk factor for CHD. First cousin unions (where the 
individuals share 1/8 of their genes) are very common in some cultures (www.consang.net) and 
could affect disease risk. From a medical genetics perspective, unions have been considered 
consanguineous if the individuals are related as second cousins or closer (F ≥0.0156). With the 
recent demonstration of previously undetected autozygosity [Broman and Weber 1999; Gibson et 
al. 2006; McQuillan et al. 2008; Nalls et al. 2009; Browning et al. 2010], genetic relatedness may 
play a larger role than initially expected.  Furthermore, health care providers need to care for 
families involved in consanguineous unions and discuss and manage potential health concerns in 
an appropriate manner [Bennett et al. 2002].  
  CHD encompasses a range of structural abnormalities of the heart, and in many cases, the 
factors that predispose an individual to disease are not well understood. At an early stage, Victor 
McKusick, a pioneer in medical genetics, summarized this issue well when he noted the common 
occurrence and complex basis of CHD [McKusick 1964]. 
  CHD associated with well-known genetic syndromes often has a known genetic basis or a 
defined Mendelian inheritance pattern. In contrast, many forms of non-syndromic CHD are 
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thought to usually result from the combined effects of a number of factors, presumably both 
genetic and epigenetic [Nora and Nora 1978]. Despite this complexity, consanguinity could 
increase the likelihood of disease, particularly if the disease has a recessive or multifactorial 
inheritance pattern. This possibility has been explored by a number of groups, who have 
attempted to quantify the potential degree of increased risk. However, these studies have varied 
in their scope, design and analysis, and as a result the conclusions drawn have been varied. For 
this review we performed a detailed analysis of recent published literature addressing 
consanguinity and congenital heart disease, in order to focus efforts on disease prevention. 
 
MATERIALS AND METHODS 
  We searched for all articles from MEDLINE (January, 1950 – March, 2010) using the 
Medical Subject Headings (MeSH) terms “heart defects, congenital” and “consanguinity,” 
limited to the English language, which yielded 207 articles. We focused on more recent articles 
that studied non-syndromic CHD given its greater incidence and its unclear genetic etiology, and 
excluded articles that considered CHD as a component of a multiple congenital anomaly 
syndrome or other well-known genetic syndromes. We compared study methodologies and 
results, and categorized studies by their different designs. 
 
RESULTS 
Consanguinity in CHD cases compared to population data for consanguinity 
  During 1998 Becker et al. examined 1013 patients with congenital heart disease in a 
major tertiary-care hospital in Riyadh, Saudi Arabia, with demographic and consanguinity 
information obtained on 891 cases by in-person interview [Becker et al. 2001]. The data were 
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then compared to rates of consanguinity from an earlier structured study of 3212 Saudi families 
[el-Hazmi et al. 1995], and the comparison indicated a statistically significant association 
between first-cousin marriage and congenital heart disease in the study population. The data 
were intriguing, however the findings may be limited as case and control groups were 
ascertained differently, although they were based on the same national population. Some 
potential confounders were mentioned, although critical factors such as socioeconomic status 
were not included in the published analyses. Nonetheless, the study was compelling as it used 
quite large subject numbers to address the role of consanguinity in CHD (Table I). 
  A study by Nabulsi et al. in Lebanon from 1997-2000 investigated CHD patients at the 
American University of Beirut Medical Center [Nabulsi et al. 2003]. The consanguinity profile 
of the 759 CHD patients was compared to the rate of consanguineous marriage in a control group 
from a national collaborative study covering approximately the same time period. When all CHD 
were considered together, 20.2% of CHD patients were born to first cousins, whereas first cousin 
marriage in the control group was maximally 13.2%, if individuals from the region with the 
highest rate of consanguinity (Bekaa) were considered. The difference in cases and controls may 
suggest an association between CHD and consanguinity, however confounders are important to 
consider. The authors analyzed a number of demographic variables in their case group, e.g. 
gender, age, education level, but limited demographic data on the control group were presented. 
It was concluded that consanguinity could lead to the segregation of autosomal recessive genes, 
but the contribution of the genes to heritability of cardiac malformations was not well 
understood. The authors also acknowledged the potential role of a multifactorial etiology in 
CHD. 
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Consanguinity in CHD cases compared to selected controls 
  A number of studies have investigated the issue of consanguinity and congenital heart 
disease, mostly utilizing smaller study sizes.  Roodpeyma et al. used a case-control design with 
346 cases of CHD admitted to Taleghani Hospital in Tehran, Iran and an equal number of 
controls enrolled over the same five-year period from admissions to the same hospital 
[Roodpeyma et al. 2002]. Their goal was to investigate the risk factors for congenital heart 
disease, and they investigated a number of variables including consanguinity. In this study, 
consanguinity was present in 22.0% of cases versus 19.1% of controls and the results did not 
attain statistical significance at p<0.05. As the study was not primarily focused on consanguinity, 
no details were published on the types of degree of relationships studied or the mean coefficient 
of inbreeding of cases and controls. 
  In South India, Ramegowda and Ramachandra aimed to maintain comparability in the 
ethnic and socio-economic backgrounds of the cases and controls groups in their study 
[Ramegowda et al. 2006]. They analyzed 144 cases of congenital heart disease ascertained from 
three major hospitals in Mysore in the state of Karnataka over two years versus 200 randomly-
selected controls selected from the same region. To assess the potential risk of consanguinity on 
CHD, they interviewed all families and obtained family histories, and representative pedigrees 
from consanguineous families were shown. As with many studies, the details of the interviews to 
assess either consanguinity or CHD were not published, leading to an assumption that the ability 
to ascertain a family history of disease was similar in cases and controls. The authors also 
incorporated parental ages into a logistic regression analysis. The parents of 15.5% of the control 
group were consanguineous versus 40.3% of the CHD families, and it was concluded that the 
study suggested an approach to studying the recessive contributions to sporadic CHDs via 
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consanguinity. Although patient age was utilized as a covariate in the analyses, further 
information regarding the specific characteristics of the case and control groups would have been 
even more helpful in interpretation of this study. 
  Yunis et al. in a study based in Beirut, Lebanon studied 173 cases of CHD from a 
perinatal collaborative network, and their 865 controls were selected from the same hospitals’ 
neonatal intensive care units [Yunis et al. 2006]. Mothers were interviewed in their native 
language and consanguinity was categorized by degrees of parental relationship.  Data regarding 
neonatal variables and maternal factors were also assessed. At first-cousin level, after controlling 
for a number of factors an adjusted odds ratio (OR) for the effect of first cousin relationships (F 
= 0.0625) on CHD of 1.8 (95% confidence interval (CI) 1.1-3.1) was reported. More distant 
consanguinity (F <0.0625) revealed an OR of 1.7 for CHD, although the 95% CI was 0.8-3.5. 
The study included control for a number of potential confounders, and the authors concluded that 
the study confirmed an association between consanguinity and CHDs among newborns in Beirut. 
  In a larger study, Chehab et al. studied 1585 cases of non-syndromic CHD from a 
pediatric heart disease registry also in Beirut, Lebanon and 1979 controls without CHD from the 
same registry [Chehab et al. 2007]. An additional control group from a UNICEF study also was 
utilized. Although the details of the collection of registry information were not described in the 
article, the authors comparatively analyzed the data from these reasonably large groups.  
Consanguinity was present in a higher proportion of CHD cases versus controls when the 
analysis was performed on first-cousins (consanguinity in 19.4% of cases versus 14.4% in 
controls) and when first- and second-cousin parental relationships (F ≥0.0156) were co-analyzed.  
On the latter basis it was concluded that all degrees of consanguinity were greater in patients 
with congenitally malformed hearts compared to controls. In recognizing differences between 
Page 7 of 21
John Wiley & Sons, Inc.
American Journal of Medical Genetics: Part A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60For Peer Review
Shieh, Bittles, and Hudgins 
8 
cases and controls the authors did address potential limitations of their study. They also 
acknowledged the importance of identifying the specific genetic risk factors in CHD and 
emphasized that the identification of genes involved in congenital malformations would improve 
counseling.  
  Some studies addressed the potential caveats in their data, e.g. Bassili et al. performed a 
case-control study in Alexandria, Egypt using the public health system to select 894 cases of 
CHD and an equal number of controls [Bassili et al. 2000]. The mothers were interviewed and 
the authors noted that a half hour was dedicated to delineating the family history and detailed 
drawing of the family pedigree of cases and controls. In this study, the authors outlined the 
demographics of the case and control groups and described their methods in some detail. Of 
particular interest was the observation that although the cases were similar to controls in many 
respects, they were more likely to be rural in residence and they tended to have less education. 
Interestingly, a history of consanguinity gave an adjusted odds ratio of 2.38 (95% confidence 
interval 1.92-2.96) for CHD. The authors discussed a number of potential sources of bias, 
including bias in selection, recall, and referral. It was concluded that consanguineous marriage 
was associated with an increased risk for CHD, and that further health education could help 
inform others about the potential effects of inbreeding. 
 
Population-based studies 
  As hospital-based studies may be affected by factors such as patient referral patterns, 
some studies have used a community-based, cross-sectional study approach (Table II). For 
example, Gev et al. tracked all children born between 1976-1983 in five villages in the Western 
Galilee region of Northern Israel [Gev et al. 1986]. Of the 1546 children born, the authors found 
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2 that had died of CHD and found 25 additional children with disease. The mothers were 
interviewed, and 14 of 498 children (2.81%) were from consanguineous marriages compared to 
13 of 1048 children (1.24%) born to non-consanguineous couples, which was statistically 
significant (p<0.02).  Badaruddoza et al. studied a population of North Indian Muslims where  
~38% of marriages were consanguineous [Badaruddoza et al. 1994]. They studied 1721 infants 
and children by tracing their genealogy to establish the degree of consanguinity between parents. 
Children were examined for potential congenital heart disease, and CHD among the parents was 
absent. They found that 12 out of 980 children from non-consanguineous parents had CHD 
(1.22%), the equivalent rates in consanguineous progeny were 13 of 295 children born to first-
cousin couples (F = 0.0625) (4.41%), 5 of 221 children from first cousins once-removed (F = 
0.0313) (2.37%), and 7 of 235 children from second-cousin parents (F = 0.0156) (2.98%). In 
total 3.37% of the children of consanguineous parents versus 1.22% of non-consanguineous 
parents had CHD. The authors concluded that their survey of homogenous population groups 
combined with the high incidence of consanguinity and the high incidence of CHD suggested a 
genetic influence and proposed that a combination of recessive genes was important for disease. 
The study is interesting in that consanguinity was traced by genealogy (and not by parental 
interview as in some other studies), potentially diminishing the possibility of reporting bias. 
  The study by El Mouzan et al. in Saudi Arabia on consanguinity and congenital heart 
disease utilized household visits by primary care physicians, with responses received on 
questions about consanguinity and major genetic diseases from 97% of 11,874 randomly-
sampled mothers [El Mouzan et al. 2008]. CHD was present in 9.1 per 1000 consanguineous 
families versus 4.3 per 1000 nonconsanguineous families, giving an OR of 2.12 (95% CI 1.27-
3.57). Although studies of this nature avoid some of the limitations of case-control studies, 
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confounders are difficult to exclude with the data presented, and the proportion of affected 
individuals identified in both the consanguineous and nonconsanguineous groups appear lower 
than in other studies. 
 
Consanguineous unions and individual CHD lesions 
  Given that many of the factors that predispose to CHD are unknown, some studies have 
considered each form of CHD separately and determined the role of consanguinity. This type of 
analysis could potentially detect effects that may be missed if multiple CHD lesions were 
considered as a single entity. Yet it is also possible that CHD displays phenotypic heterogeneity 
and multiple types of CHD may result from a genetic predisposition, as suggested by individual 
families that harbor individuals with different forms of congenital heart disease. 
Considering the effect of consanguinity on disease based on studies that stratified the 
type of cardiac lesion, the previously discussed study by Becker et al. (2001) concluded that 
atrioventricular septal defect (AVSD), pulmonary atresia, pulmonic stenosis, ventriculoseptal 
defect (VSD), and atrial septal defect (ASD) were associated with consanguinity. Conversely, 
Ramegowda and Ramachandra (2006) concluded that ASD and patent ductus arteriosus (PDA) 
were strongly influenced by consanguinity, but they found no significant association of 
consanguinity with VSD or with complex congenital heart disease. Although intriguing, the 
conclusions of the study could be subject to a few potential limitations. First, the number of cases 
of ASD or PDA (26 or 14 respectively) was relatively small, although other studies also utilized 
low numbers of cases. Furthermore, confounding could always be present given the limited 
information published, and this has been discussed (Bittles 2007). 
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Bassili et al. reported that VSD (OR 2.70, 95% CI 2.07-3.50) and ASD (OR 2.87, 95% CI 
1.85-4.47) were associated with consanguinity. Nabulsi et al. reported a significantly higher 
proportion of first-cousin marriages with many individual types of CHD including aortic valvular 
anomalies, ASD, and Tetralogy of Fallot (TOF), VSD, and pulmonic stenosis. 
  In the study by Chehab et al. a larger number of cases and controls were analyzed.  The 
authors analyzed the degree of consanguinity in certain individual lesions and concluded that 
cases with ASD (total cases, n=136), valvular aortic stenosis (n=86), and TOF (n=44) 
demonstrated a significantly stronger association with consanguinity in the cases than the 
controls. However, consanguinity in cases with valvular pulmonary stenosis (with first-cousin 
offspring in 46 of 258 cases) did not differ significantly from the controls. VSDs were 
significantly associated with first cousin parentage, but not when first and second degree cousins 
were co-analyzed.  ASDs were also associated with first and second cousin parentage. 
  In the article by Yunis et al., congenital heart disease subtype analysis was performed and 
VSD was associated with first cousin consanguinity. This finding was extended using 
multivariate analysis, which gave an adjusted OR of 2.5 (95% CI 1.1-5.6).  ASD and hypoplastic 
left heart were also mentioned, although a full analysis was not performed since the numbers of 
these cases were smaller. 
  It seems that the majority of studies conclude that there is an increased incidence of 
septal defects such as VSD and ASD in the setting of consanguinity. This may reflect the fact 
that with more common forms of congenital heart disease, the higher incidence likely gives more 
power to determine the effect of consanguinity. Furthermore, conflicting conclusions may be 
largely based on differences in the groups studied and the methods of analysis.   
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DISCUSSION 
  The majority of studies support a relationship between consanguineous parentage and 
congenital heart disease (Tables I and II). However, it is important that the conclusions drawn 
from each study are viewed in the light of their respective strengths and limitations. Many 
studies used a case-control design and included cases of CHD diagnosed by methods such as 
echocardiography and excluded cases with known chromosome abnormalities or multiple 
congenital abnormalities. These studies can identify reasonably large numbers to study, however 
the analyses of cases and controls are critical.  A few important points need to be considered: 
First, to what extent could confounding play a role in differences between case and control 
groups? Could the choice of certain cases or controls inadvertently lead to elevated or deflated 
effect sizes that are attributed to consanguinity? Many of these studies used controls from the 
same hospital or from the geographic region as the cases to minimize potential confounders. 
Second, how was consanguinity defined and determined?  Most studies determined 
consanguinity considering at least first and second cousin unions, although some studies failed to 
indicate how consanguinity had been defined. Familial consanguinity also relied largely on the 
report by the parent of a child with congenital heart disease. Given this commonly used 
technique, it is important to minimize the possibility of reporting bias in eliciting the history of 
consanguinity to assure that the investigation for consanguinity is equally efficient in cases and 
controls. Details such as these are important to consider when drawing conclusions from studies. 
  Despite these potential issues, most studies conclude that certain lesions such as septal 
defects are increased in incidence in the setting of consanguinity. Whether less common heart 
lesions follow a similar pattern is unclear. Future population-based studies that capture large 
numbers of lesions and that quantify relatedness will be helpful. 
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  Counseling families with consanguinity and congenital heart disease is often performed 
as for other multifactorial conditions. In the absence of a recognizable pattern of disease 
inheritance, families are presented with an empiric risk for congenital heart disease based on 
population data that may or may not take into account the type of heart lesion. This risk may be 
modified depending on the individual family history and other clinical risk indicators, and may 
be further adjusted due to the presence of consanguinity, although the degree of risk used in 
counseling has been variable [Bennett et al. 1999]. Based on our review of these studies, we 
recognize that future large population-based studies of birth defects such as congenital heart 
diseases should incorporate measures of genetic relatedness into their assessment and analysis. 
  Since it is uncommon for isolated congenital heart disease to be inherited in a classic 
Mendelian manner, most cases are assumed to be complex. For such multifactorial diseases, our 
ability to discuss and present precise risks to a concerned family is directly related to our 
understanding of the basis of disease.  Based on the studies reviewed here, which are the best 
currently available, we still need to strive to understand the relative contribution of genetics 
versus the environment in congenital heart disease. If we can determine the proportional effect of 
consanguinity on disease, this may help determine the genetic contribution to a specific complex 
condition or the comparative role of genetics versus environmental influences. 
  As the effect of consanguinity on the risk of congenital heart disease decreases, one 
would hypothesize that there could be potentially a larger number of low-effect genes involved 
in the disease (or less of a genetic contribution) and more potential environmental contribution.  
Indeed, environmental factors such as blood flow are clearly important in early heart 
development, yet its contribution is difficult to assess in current human studies.  Furthermore, if 
teratogens [Lammer et al. 1985; Malik et al. 2008] such as rubella or alcohol can contribute to 
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the risk of congenital heart disease, there is clearly a role for understanding how the 
environmental influences lead to disease [Jenkins et al. 2007] given a susceptible genetic 
background.  
  The current discussion on consanguinity and risk for congenital heart disease is timely 
given the possibility for future more informative studies. Given the enormous growth in the 
ability to genotype individuals based on detection of single nucleotide polymorphisms (SNPs), 
we now can determine the ethnic ancestry of an individual based on genetics alone, and the 
application of next generation methodologies will greatly increase this analytical capacity.  Such 
genomic identity may be able to more precisely estimate the degree of genetic relatedness and 
identify consanguineous relationships that could have been missed or miscategorized based on 
self-report. 
Genome-scale SNP identification has also identified regions of extended loss of 
heterozygosity in normal individuals, which could be a result from past consanguinity [Broman 
and Weber 1999; Gibson et al. 2006; McQuillan et al. 2008; Nalls et al. 2009], and further 
studies are needed to elucidate the role of these regions in disease [McGregor et al. 2010]. The 
volume of genetic information available is rapidly expanding and the technology is available to 
sequence entire exomes or genomes for detection of SNPs or small copy number variants that 
could influence disease. These types of studies will reveal potentially common or rare variants 
associated with disease, and it will be possible to assess the role of these predisposing factors in 
the setting of consanguineous families. 
The influence of de novo changes on oligogenic disease is also unknown, however it is 
possible that these genomic alterations combined with the effects of consanguinity could bring 
together the requisite components for disease. Furthermore, the epigenetic factors that contribute 
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to CHD are largely unknown [Shieh and Srivastava 2009], and it is unclear if consanguinity 
results in shared environmental contributions to disease. Different populations may be 
differentially susceptible to genetic and environmental perturbations, and it is important to 
continue these studies with a global perspective. 
  If we can develop a better understanding of the relationship between consanguinity and 
congenital heart disease, we can implement more accurate genetic counseling and more effective 
clinical management.  We propose emphasis in four key areas: (1) With patients involved in 
consanguineous unions, to discuss potential implications on health based on the family history 
and clinical assessment. A consanguineous union may result in a greater risk for congenital heart 
disease based on studies presented in the literature, but the bias towards publication of positive 
findings merits consideration, and the magnitude of risk should be taken in context of the 
individual history and other potential indicators of disease. (2) Continue to educate healthcare 
providers and patients about the importance of the medical family history. (3) Promote a 
balanced understanding of consanguinity and develop patient skills to effectively manage 
familial health risks.  (4) Prioritize disease prevention and investigation into genetic 
predispositions to disease and integrate cultural issues such as consanguinity into global health 
initiatives. 
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Table I. Results of studies of consanguinity and congenital heart disease 
 
    No. subjects  Percent with consanguinity   
Study  Country  CHD  Controls  CHD  Controls  Reported statistics 
Becker et al. 2001  Saudi Arabia  891  3212  40.4%
a  28.4%  Z 
statistic 
P<0.001 
Nabulsi et al. 2003  Lebanon  759  19,589  20.2%
 a  13.2%  Χ
2  P<0.0001 
Roodpeyma et al.  2002  Iran  346  346  22%  19.1%  Χ
2  NS 
Ramegowda et al. 2006   India  144  200  40.3%  15.5% 
b  P=0.0001 
Yunis et al. 2006   Lebanon  173  865  17.9%
 a  9%  Χ
2  P<0.001 
Chehab et al.  2004  Lebanon  1585  1979  19.4%
 a  14.4%  Χ
2  P<0.0001 
Bassili et al. 2000  Egypt  894  894  44.1%  23.8% 
c   
a First-cousin consanguinity 
b Data not available
  
c Average inbreeding coefficient 0.021 in CHD cases versus 0.011 in controls (P<0.05) 
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Table II. Results from population studies of consanguinity and congenital heart disease 
 
          No. Subjects     Percent with CHD     
Study  Country.  Total  Consang. Non-consang.  Consang.  Non-consang.  Reported statistics 
Gev et al. 1986  Israel  1546
a  373
b  1048  3.22%
 b  1.24%  Χ
2  P<0.02 
Badaruddoza et al. 1994   India  1721
a  295
 b  980  4.41%
 b  1.22%  Χ
2  P<0.001 
El Mouzan et al. 2008   Saudi Arabia 11,554
 a  6470
 a  5084  0.091%  0.043%  Χ
2  P<0.003 
a Includes first cousin and other consanguinity 
b First-cousin consanguinity 
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